Matsumura T, Yoshihama Y, Kimura T, Shintani S, Alcalde R E
Department of Oral and Maxillofacial Surgery II, Okayama University Dental School, Japan.
Oncology. 1996 Jul-Aug;53(4):308-12. doi: 10.1159/000227578.
The p53 tumor suppressor gene is the most commonly mutated gene in human cancer and is a frequent abnormality in oral squamous cell carcinoma and its precancerous lesions. MDM2 (murine double minute-2), a new proto-oncogene, may be associated with p53 gene products and may negatively affect the transcriptional activating function of p53. The purpose of this study was to investigate the incidence of MDM2 and its relationship to the expression of p53 in oral squamous cell carcinoma and precancerous lesions. Overexpression of p53 and MDM2 proteins was detected in 52 and 40% of oral squamous cell carcinomas, respectively. p53 gene mutation, absent in normal oral epithelium was observed in 31% of the carcinoma cases. Our finding suggested that MDM2 protein may be an alternative mechanism causing p53 protein dysfunction in oral squamous cell carcinoma.
p53肿瘤抑制基因是人类癌症中最常发生突变的基因,在口腔鳞状细胞癌及其癌前病变中也经常出现异常。MDM2(小鼠双微体-2)是一种新的原癌基因,可能与p53基因产物相关,并可能对p53的转录激活功能产生负面影响。本研究的目的是调查MDM2在口腔鳞状细胞癌和癌前病变中的发生率及其与p53表达的关系。分别在52%和40%的口腔鳞状细胞癌中检测到p53和MDM2蛋白的过表达。在31%的癌病例中观察到正常口腔上皮中不存在的p53基因突变。我们的研究结果表明,MDM2蛋白可能是导致口腔鳞状细胞癌中p53蛋白功能障碍的另一种机制。